|
Amyloid b-Peptide (1-40) (human) (1 mg) |
1191 |
1 mg |
TOCRIS |
|
|
|
|
Amyloid b-peptide (1-42) (rat) (500 ug) |
2425 |
500 ug |
TOCRIS |
|
|
|
|
Amyloid b-peptide (25-35) (human) (1 mg) |
1429 |
1 mg |
TOCRIS |
|
|
|
|
Amyloid b-peptide (42-1) (human) (100 ug) |
3391 |
100 ug |
TOCRIS |
|
|
|
|
Amyloid beta-peptide (1-42) (human) (100 ug) |
1428 |
100 ug |
TOCRIS |
|
|
|
|
Ac-Amyloid ß-Protein (15-20) amide [Ac-Gln-Lys-Leu-Val-Phe-Phe- NH2 (MW: 8223)] |
SP-89301-5 |
5 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Ac-[Pro18, Asp21] ß- Amyloid (17 - 21), amide, iAb5p Pro18 Asp21 [Ac-Leu-Pro-Phe-Phe-Asp-NH2 (MW: 678.79)] |
SP-87940-5 |
5 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Amyloid (1-40), Rat [H-Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Gly-Val-Arg-His-Gin-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH; MW: 4233.81] |
SP-53770-1 |
0.5 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Amyloid (1-42), Human [H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lyn-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH; MW: |
SP-52487-1 |
0.5 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Amyloid (25-35) peptide [H-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Oh; MW: 1060.3] |
SP-51106-1 |
5 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Amyloid Bri Protein (1-23) (AA:Glu-Ala-Ser-Asn-Cys-Phe-Ala-Ile-Arg-His-Phe-Glu-Asn-Lys-Phe-Ala-Val-Glu-Thr-Leu-Ile-Cys-Ser ?
(Disulfide bridge:Cys5-Cys22)) (MW: 26280) |
SP-83872-05 |
0.5 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Amyloid Bri Protein (1-34) (AA: Pyr-Ala-Ser-Asn-Cys-Phe-Ala-Ile-Arg-His-Phe-Glu-Asn-Lys-Phe-Ala-Val-Glu-Thr-Leu-Ile-Cys-Ser-Arg-Thr-Val-Lys-Lys-Asn-Ile-Ile-Glu-Glu-Asn (Disulfide bridge: Cys5-Cys22)) |
SP-89286-05 |
0.5 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Amyloid Bri Protein (1-34) (reduced) (AA: Pyr-Ala-Ser-Asn-Cys-Phe-Ala-Ile-Arg-His-Phe-Glu-Asn-Lys-Phe-Ala-Val-Glu-Thr-Leu-Ile-Cys-Ser-Arg-Thr-Val-Lys-Lys-Asn-Ile-Ile-Glu-Glu-Asn) (MW: 3937.55) |
SP-89285-05 |
0.5 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Amyloid Bri Protein Precursor277 (89-106) (AA: Cys-Gly-Ile-Lys-Tyr-Ile-Lys-Asp-Asp-Val-Ile-Leu-Asn-Glu-Pro-Ser-Ala-Asp) (MW: 1993.27) |
SP-89287-1 |
1 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Amyloid Dan Protein (1-34) (AA: Pyr-Ala-Ser-Asn-Cys-Phe-Ala-Ile-Arg-His-Phe-Glu-Asn-Lys-Phe-Ala-Val-Glu-Thr-Leu-Ile-Cys-Phe-Asn-Leu-Phe-Leu-Asn-Ser-Gln-Glu-Lys-His-Tyr (Disulfide bridge:Cys5-Cys21)) |
SP-89288-1 |
1 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Amyloid Dan Protein (1-34) (reduced) (AA: Pyr-Ala-Ser-Asn-Cys-Phe-Ala-Ile-Arg-His-Phe-Glu-Asn-Lys-Phe-Ala-Val-Glu-Thr-Leu-Ile-Cys-Phe-Asn-Leu-Phe-Leu-Asn-Ser-Gln-Glu-Lys-His-Tyr) (MW: 4046.63) |
SP-89290-1 |
1 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Amyloid P Component (33-38) amide (AA: Phe-Thr-Leu-Cys-Phe-Arg-NH2) (MW: 784.98) |
SP-89284-5 |
5 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Amyloid Peptide(1-42), Rat [H-Asp-Ala-Gly-Phe-Gly-His-Asp-Ser-Gly-Phe-Gly-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gly-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH |
SP-53771-1 |
0.5 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Amyloid ß-Protein (1-43) (AA: Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-Th |
SP-89298-1 |
1 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Amyloid ß-Protein (20-29) (AA: Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly) (MW: 10238) |
SP-89304-5 |
5 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Amyloid ß-Protein (25-35) amide (AA: Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-NH2) (MW: 1059.31) |
SP-89305-5 |
5 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Amyloid ß-Protein (29-40) (AA: Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val) (MW: 1085.38) |
SP-62497-1 |
1 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Amyloid ß-Protein (33-42) (AA: Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala) (MW: 915.17) |
SP-80702-5 |
5 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Amyloid ß-Protein (42-1) (AA: Ala-Ile-Val-Val-Gly-Gly-Val-Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly-Val-Asp-Glu-Ala-Phe-Phe-Val-Leu-Lys-Gln-His-His-Val-Glu-Tyr-Gly-Ser-Asp-His-Arg-Phe-Glu-Ala-Asp) ( |
SP-53819-1 |
1 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Amyloid ß-Protein (6-20) (AA: His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe) (MW: 18435) |
SP-71897-1 |
1 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Amyloid ß/A4 Protein Precursor770 (667-676) (AA: Ser-Glu-Val-Lys-Met-Asp-Ala-Glu-Phe-Arg) (MW: 1211.37) |
SP-89314-5 |
5 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Amyloid ß/A4 Protein Precursor770 (740-770) (AA: Ala-Ala-Val-Thr-Pro-Glu-Glu-Arg-His-Leu-Ser-Lys-Met-Gln-Gln-Asn-Gly-Tyr-Glu-Asn-Pro-Thr-Tyr-Lys-Phe-Phe-Glu-Gln-Met-Gln-Asn) (MW: 3717.14) |
SP-72257-1 |
1 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
beta-Amyloid(1-40), UltraPure, TFA; H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH |
SP-51516 |
1 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Beta-Human Amyloid 1-40 (C-terminal, 8 aa) Control/blocking peptide # 1 |
BAM401-P |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Beta-Human Amyloid 1-42 (C-terminal, 8 aa) Control/blocking peptide # 1 |
BAM421-P |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Biotin-Amyloid ß-Protein (1-40) (AA: Biotin-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val- |
SP-56317-1 |
1 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Biotin-Amyloid ß-Protein (1-42) (AA: Biotin-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val- |
SP-89295-1 |
1 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Cys-Gly-His-Gly-Asn-Lys-Ser-Amyloid ß -Protein (33-40) (AA: Cys-Gly-His-Gly-Asn-Lys-Ser-Gly-Leu-Met-Val-Gly-Gly-Val-Val) (MW: 1414.67) |
SP-89307-1 |
1 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Cys-Gly-Lys-Arg-Amyloid - ß Protein (1-42) (AA: Cys-Gly-Lys-Arg-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu- |
SP-89296-1 |
1 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Cys-Gly-Lys-Lys-Gly-Amyloid ß-Protein (35-40) (AA: Cys-Gly-Lys-Lys-Gly-Met-Val-Gly-Gly-Val-Val) (MW: 1034.31) |
SP-89309-5 |
5 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Cys-Gly-Lys-Lys-Gly-Amyloid ß-Protein (33-40) (AA: ys-Gly-Lys-Lys-Gly-Gly-Leu-Met-Val-Gly-Gly-Val-Val) (MW: 1203.52) |
SP-89308-5 |
5 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Cys-Gly-Lys-Lys-Gly-Amyloid ß-Protein (36-42) (AA: Cys-Gly-Lys-Lys-Gly-Val-Gly-Gly-Val-Val-Ile-Ala) (MW: 1087.35) |
SP-89310-5 |
5 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Cys-Gly-Lys-Lys-Gly-Amyloid ß-Protein (37-42) (AA:Cys-Gly-Lys-Lys-Gly-Gly-Gly-Val-Val-Ile-Ala) (MW: 988.22) |
SP-89311-5 |
5 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Cys-ß- Amyloid (1 - 40) (AA: Cys-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val) (MW: 4 |
SP-79774-1 |
1 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Cys-ß- Amyloid (12 - 28) (AA: Cys-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys) (MW: 2057.36) |
SP-87999-1 |
1 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
ent-Amyloid b-Protein (1-42) |
SP-89297-1 |
1 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Gly22] -ß- Amyloid (1 - 40) [Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gly-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val; MW: 4257.8 |
SP-74049-1 |
1 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Human Amyloid precursor protein (APP) Control/blocking peptide # 4 |
APP14-P |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Human Amyloid precursor protein (APP) control/blocking peptide #2 |
APP12-P |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Human Amyloid precursor protein (APP770) Control/blocking peptide |
APP11-P |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Human beta amyloid 10-24 aa Control/blocking peptide # 4 |
BAM404-P |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Human beta-Amyloid 1-40 (full length) peptide |
BAM400-P1000 |
1 mg |
ALPHA DIAGNOSTICS |
|
|
|
|
Human beta-Amyloid 1-40 (full length) peptide |
BAM400-P |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Human Beta-Amyloid 1-40 Control/blocking peptide |
BAM402-P |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Human beta-Amyloid 1-42 (full length) peptide |
BAM422-P1000 |
1000 ug |
ALPHA DIAGNOSTICS |
|
|
|